Apeloa Pharmaceutical Co.,Ltd
000739
Rangering i aksjer
#4312
Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical... Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical enterprise, specializing in the discovery, development, production, and global distribution of a diverse range of medicinal products. Its market reach spans China and various international territories. The company strategically focuses its product portfolio on several critical medical fields, including cardiovascular and cerebrovascular health, anti-infective treatments, antiviral therapies, and oncology (cancer treatment), alongside other therapeutic categories. Apeloa's offerings encompass finished pharmaceutical preparations, raw material intermediates (active pharmaceutical ingredients and their precursors), and veterinary medicines. These products are primarily recognized and sold under key brands such as Tianliwei, Beshin, Yosemade, and Jutai, among others. Furthermore, the company extends its expertise to other pharmaceutical businesses by providing contract research, development, and manufacturing (CDMO) services. The corporate headquarters for Apeloa Pharmaceutical Co.,Ltd are located in Dongyang, China.
Aksjekurs
$3.17
Markedsverdi
$3.67B
Endring (1 dag)
0.76%
Endring (1 år)
40.57%
Land
CN
Handel Apeloa Pharmaceutical Co.,Ltd (000739)
Kategori
Healthcare
EPS for Apeloa Pharmaceutical Co.,Ltd (000739)
EPS per June 2026 TTM: $0.11
Ifølge de siste økonomiske rapportene og aksjekursen til Apeloa Pharmaceutical Co.,Ltd er selskapets nåværende EPS (TTM) $0.11. Ved slutten av 2023 hadde selskapet en EPS på $0.13, en økning sammenlignet med EPS-en i 2022 som var $0.12.
EPS-historikk for Apeloa Pharmaceutical Co.,Ltd fra 2000 til 2026
EPS ved slutten av hvert år
| År | EPS | Endre |
|---|---|---|
| 2026 (TTM) | $0.11 | -9.42% |
| 2024 | $0.12 | -4.09% |
| 2023 | $0.13 | 3.17% |
| 2022 | $0.12 | -3.30% |
| 2021 | $0.13 | 20.64% |
| 2020 | $0.11 | 56.44% |
| 2019 | $0.07 | 47.70% |
| 2018 | $0.05 | 35.21% |
| 2017 | $0.03 | 2.11% |
| 2016 | $0.03 | 19.49% |
| 2015 | $0.03 | -42.77% |
| 2014 | $0.05 | 39.88% |
| 2013 | $0.03 | -22.94% |
| 2012 | $0.04 | 265.04% |
| 2011 | $0.01 | 136.54% |
| 2010 | $0.01 | -30.67% |
| 2009 | $0.01 | 17.19% |
| 2008 | $0.01 | -3.03% |
| 2007 | $0.01 | -45.00% |
| 2006 | $0.01 | 57.89% |
| 2005 | $0.01 | 24.59% |
| 2004 | $0.01 | 5.17% |
| 2003 | $0.01 | 7.41% |
| 2002 | $0.01 | -210.20% |
| 2001 | 0.00 | 716.67% |
| 2000 | 0.00 | 0.00% |
EPS for lignende selskaper eller konkurrenter
| Selskap | EPS | EPS-forskjell | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | 411.78% |
IN
|
